Scientific Programme

Preliminary programme and confirmed speakers


MONDAY 24th August 2020




Diagnosis, risk factors and prognosis of TIA and minor stroke

  1. Diagnosis, significance, and management of blood pressure variability in cerebrovascular diseases

  2. Long term risks of vascular events and management after TIA and minor stroke

  3. New perspectives in imaging of transient ischaemia


Prehospital management of acute ischemic stroke :

  1. Mobile Stroke unit : Effects on process indicators, outcomes and cost utility
    Heinrich Audebert (Berlin)

  2. Debate : mother ship vs drip and ship

    1. Utility of prehospital score to predict large artery disease

      Guillaume Turc (Paris)

    2. Place of geographic modelling of best transport option for treatment of acute ischemic stroke
      Ludwig Schlemm (London)

    3. Is there a need for randomized trials ?
      Natalia Pérez de la Ossa (Barcelone)
      Richard Macrez (Caen)


TUESDAY 25th August 2020

New perspectives in endovascular treatment

  1. Interventional vascular medicine with robotic assistance (Robocath)  
    Philippe Bencteux (Rouen)

  2. Automated core-penumbra quantification in acute ischemic stroke : principles and different tools  

  3. Best strategies for endovascular treatment (combined devices of aspiration and stent retriever: update of evidence and current trials
    Bertrand Lapergue (Paris)

  4. Mechanical thrombectomy in minor stroke and very severe stroke
    Urs Fischer (Bern)


IV thrombolytic agents

  1. Treatment with IV thrombolysis over 4.5h after stroke onset: how many patients in practice ? How could we implement this in routine ?
    Didier Leys (Lille)

  2. When tenectepalse should be preferred over alteplase ?
    Daniel Strbian (Helsinki)

  3. Molecular imaging of clots to predict therapeutic response
    Maxime Gauberti (Caen)

  4. How to improve the thrombolytic effect of alteplase and to reduce the risk of bleeding, alteplase mutants ?
    Denis Vivien (Caen)

  5. New antithrombotic targets: antiGP6, antiGP1, von Willebrand
    Sara Martinez de Lizarrondo (Caen)

 WEDNESDAY 26th August 2020

Genetics of stroke :

  1. How to interpret SNP, GWAS (with examples in stroke diseases)
    Stéphanie Debette (Bordeaux)

  2. Omics techniques
    Martin Dichgans (Munich)

  3. New approaches in gene and cellular therapies (CRISPr)

  4. Ethical issues in molecular diagnostic of inherited cerebrovascular disorders » (with examples of stroke diseases)
    Elisabeth Tournier-Lasserve (Paris)


Small vessel diseases

  1. Small vessel diseases: pathophysiology, classification, genetics
    Eric Jouvent (Paris)

  2. Animal models of small vessel diseases 
    Anne Joutel (Paris)

  3. Cerebral vasculitis

  4. Cerebral amyloid angiopathy


Meeting of the executive committee on Wednesday afternoon


THURSDAY 27th August 2020

Heart and stroke

  1. Imaging of sporadic haemorrhagic cerebral microangiopathies
    Grégoire Boulouis (Paris)

  2. Whether to resume or not antithrombotic therapies after intracerebral haemorrhage

  3. Indications and complications of left appendage closure in stroke patients with atrial fibrillation

  4. Patent foramen ovale closure in patients not included in trials: TIA patients, age > 60 years, delay from stroke > 6 months-1 year

  5. Place of implantable cardiac monitors in cryptogenic stroke ?


Neurosurgery in stroke

  1. Hemicraniectomy for ischaemic and haemorrhagic stroke
    Bart van der Worp (Utrecht)

  2. Local thrombolytic therapies in intraventricular haemorrhage: rationale, update of recent and future trials


FRIDAY 28th August 2020

Workshop in the laboratory

  • Visit of a pre-clinical laboratory, animal and in vitro models of aneurysm, ischaemic stroke and haemorrhagic stroke


Statistical analyses for dummies

  • Interpretation of trials outcomes (OR, RR, HR)

  • Subgroup analyses

  • Meta-analyses

  • Interim analyses

© 2023 by Networking Talks.  Proudly created with

This site was designed with the
website builder. Create your website today.
Start Now